oxiracetam has been researched along with Alzheimer Disease in 6 studies
oxiracetam: structure in first source
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oxiracetam (ORC) was used as a positive drug in this experiment." | 1.62 | Poria cocos polysaccharide attenuates damage of nervus in Alzheimer's disease rat model induced by D-galactose and aluminum trichloride. ( Jiang, Y; Ling, Y; Zhang, Y; Zhou, C; Zhou, X, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, X | 1 |
| Zhang, Y | 1 |
| Jiang, Y | 1 |
| Zhou, C | 1 |
| Ling, Y | 1 |
| Bottini, G | 1 |
| Vallar, G | 1 |
| Cappa, S | 1 |
| Monza, GC | 1 |
| Scarpini, E | 1 |
| Baron, P | 1 |
| Cheldi, A | 1 |
| Scarlato, G | 1 |
| Green, RC | 1 |
| Goldstein, FC | 1 |
| Auchus, AP | 1 |
| Presley, R | 1 |
| Clark, WS | 1 |
| Van Tuyl, L | 1 |
| Green, J | 1 |
| Hersch, SM | 1 |
| Karp, HR | 1 |
| Villardita, C | 1 |
| Grioli, S | 1 |
| Lomeo, C | 1 |
| Cattaneo, C | 1 |
| Parini, J | 1 |
| Parnetti, L | 1 |
| Mecocci, P | 1 |
| Petrini, A | 1 |
| Longo, A | 1 |
| Buccolieri, A | 1 |
| Senin, U | 1 |
| Gainotti, G | 1 |
| Nocentini, U | 1 |
| Sena, E | 1 |
4 trials available for oxiracetam and Alzheimer Disease
| Article | Year |
|---|---|
Oxiracetam in dementia: a double-blind, placebo-controlled study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Attention; Dementia, Multi-Infarct; Double-Blind Method; | 1992 |
Treatment trial of oxiracetam in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cognition Disorders; Double-Blind Method; Humans; Neuropsychological Tests; | 1992 |
Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree.
Topics: Aged; Alzheimer Disease; Cognition Disorders; Dementia, Multi-Infarct; Double-Blind Method; Female; | 1992 |
Can the pattern of neuropsychological improvement obtained with cholinergic drugs be used to infer a cholinergic mechanism in other nootropic drugs?
Topics: Alzheimer Disease; Clinical Trials as Topic; Cognition; Cognition Disorders; Double-Blind Method; Hu | 1989 |
2 other studies available for oxiracetam and Alzheimer Disease
| Article | Year |
|---|---|
Poria cocos polysaccharide attenuates damage of nervus in Alzheimer's disease rat model induced by D-galactose and aluminum trichloride.
Topics: Aluminum Chloride; Alzheimer Disease; Animals; Apoptosis; Behavior, Animal; Cognition; Cognitive Dys | 2021 |
Neuropsychological results of long-term therapy with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia in comparison with a control group.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia, Multi-Infarct; Female; Humans; Long-Term Care; | 1989 |